Hints and tips:
Related Special Reports
...Patrick Smith, a lawyer for Dagar, said his client denied the charges. “Nobody at Pfizer ever told Mr Dagar, who was on the ‘blinded’ side, the results of the Paxlovid trial,” he added....
...“The drive to renegotiate agreements is not unique to Novavax but they are more pressed against a wall because of their difficult financial situation,” said Brendan Smith, analyst at Cowen, an investment...
...The show’s editor is Jess Smith. Additional help by Peter Barber, Michael Lello, David da Silva and Gavin Kallmann. Topher Forhecz is the FT’s executive producer....
...Smith has looked into one of the problems that has taken the shine off Paxlovid....
...A taipan’s memories For those interested in the inner workings of Hong Kong Inc, as well as a melancholy reminder of how much both the territory and China-US commercial relations have changed for the worse...
...Its share price has languished since chief executive Alan Jope took over in 2019, and top-10 investor Terry Smith this week attacked the company as “labouring under the weight of a management which is obsessed...
...Rivals AstraZeneca, Johnson & Johnson, Russia’s Sputnik V and new entrants such as Novavax make up the remainder of the market, which is forecast to double in value to $124bn next year....
...Attendees include Disney’s chief executive Bob Chapek, Microsoft’s president Brad Smith and Business Roundtable head Joshua Bolten....
...Gayle Smith, head of global Covid-19 response at the US state department, told the Financial Times she wanted US vaccine makers — which include Moderna, Pfizer and Johnson & Johnson — to share technological...
...FedEx, which has shipped about half of vaccine doses in the US, is struggling with record volumes, though Richard Smith, the company’s regional president for the Americas, told the FT the jab deliveries...
...The AU will pay $6.75 a dose for the BioNTech/Pfizer vaccine and $10 for Johnson & Johnson’s, a single-dose product....
...Slovakia’s prime minister said he was ready to stand down to defuse a crisis over his decision to purchase Russia’s Sputnik V vaccine, which has not been approved by Europe’s regulator....
...Experts expect other leading vaccines, such as those made by BioNTech/Pfizer, Moderna, Novavax and Johnson & Johnson, to have similar effects though hard data are not yet available....
...Germany’s BioNTech and US pharmaceutical company Pfizer said doses of the vaccine would be delivered to the UK in the coming days after the UK’s Medicines and Healthcare products Regulatory Agency (MHRA)...
...Julian Smith, former Northern Ireland secretary, said the EU had “pulled the emergency cord” without following the proper processes that had been agreed over years of negotiations....
...After such strong reads from the first two releases (three if we count Russia’s Sputnik V), the disappointing AZN figures were perhaps bound to prompt downward pressure on the company’s shares....
...In August, Russia became the first country to approve a Covid-19 vaccine — named Sputnik V — for civilian use, but western experts cast doubt on its efficacy and safety....
...The EU medicines regulator has approved Pfizer/BioNTech’s Covid-19 vaccine. Germany and Switzerland halted flights from South Africa over the new virus strain....
...Meanwhile, the African Union announced that it had secured 300m doses of Russia’s Sputnik V vaccine, which has also been sold to countries including Algeria, Argentina and Brazil....
...He spotted the value in an unloved unit of just 25 people still working on inoculations, led by Gale Smith, now Novavax’s vice-president of vaccine development....
...Gayle Smith, president of the ONE Campaign against global poverty, says a lack of global co-ordination threatens to prolong the pandemic....
...The US administration has committed to spending $1.95bn on 100m doses of a potential Covid-19 vaccine being developed by Germany’s BioNTech and US pharma giant Pfizer....
...Brunswick Group hired former Pfizer China government affairs vice-president Xi Qing as a partner in Asia....
...US outfits such as Cadwalader, Wickersham & Taft, Reed Smith, BCLP and Baker McKenzie have moved swiftly to cut both payouts for partners and salaries for more junior lawyers — going further than most UK...
...White & Case has hired Will Smith as a partner in the firm’s global tax practice in London. Smith joins from Sidley Austin....
International Edition